Prem Watsa · Q4 2024
Fairfax Financial Holdings
Portfolio at the end of Q4 2024, from the 13F filed February 14, 2025. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Orla Mining ORLA · history | 20.0% | Q3 2022 | No change |
| Occidental Petroleum OXY · history | 19.1% | Q2 2022 | No change |
| BlackBerry BB · history | 11.3% | Q2 2013 or earlier | No change |
| Kennedy-Wilson KW · history | 8.6% | Q2 2013 or earlier | No change |
| CVS Health CVS · history | 7.8% | Q4 2024 | Buy |
| Kraft Heinz KHC · history | 6.5% | Q3 2024 | Add 342% |
| ATS ATS · history | 4.7% | Q3 2024 | Add 4285% |
| Molson Coors Beverage TAP · history | 4.4% | Q4 2024 | Buy |
| Cleveland-Cliffs CLF · history | 3.6% | Q4 2024 | Buy |
| Under Armour UAA · history | 3.4% | Q2 2024 | No change |
| TSMC TSM · history | 1.8% | Q3 2017 | No change |
| Helmerich & Payne HP · history | 1.6% | Q1 2015 | Add 39% |
| General Motors GM · history | 1.3% | Q2 2018 | No change |
| Bank of Nova Scotia BNS · history | 1.2% | Q4 2018 | Add 24% |
| Pfizer PFE · history | 1.1% | Q4 2020 | Add 41% |
| Merck MRK · history | 1.1% | Q4 2020 | No change |
| Johnson & Johnson JNJ · history | 0.7% | Q2 2013 or earlier | No change |
| Micron Technology MU · history | 0.4% | Q4 2018 | No change |
| KKR KKR · history | 0.2% | Q4 2019 | No change |
| Colliers International Group CIGI · history | 0.2% | Q4 2019 | No change |
| Garrett Motion GTX · history | 0.2% | Q2 2021 | Add 7% |
| Gentex GNTX · history | 0.2% | Q4 2022 | No change |
| Franco-Nevada FNV · history | 0.1% | Q4 2023 | No change |
| TFI International TFII · history | 0.1% | Q2 2022 | No change |
| Capri Holdings CPRI · history | 0.1% | Q3 2023 | Reduce 61% |
| Autohome ATHM · history | 0.1% | Q1 2022 | No change |
| MGM Resorts International MGM · history | 0.1% | Q2 2022 | No change |
| Berkshire Hathaway BRK.A · history | 0.0% | Q2 2013 or earlier | No change |
| Magnachip Semiconductor MX · history | 0.0% | Q2 2021 | No change |
| Xeris Biopharma XERS · history | 0.0% | Q4 2021 | Reduce 18% |
| Revance Therapeutics RVNC · history | 0.0% | Q4 2024 | Buy |
| 31 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2024, adjusted for stock splits.
Sector weighting
| Materials | 23.7% | |
|---|---|---|
| Energy | 20.7% | |
| Technology | 13.7% | |
| Consumer staples | 10.9% | |
| Health care | 10.8% | |
| Financials & real estate | 10.3% | |
| Consumer discretionary | 5.0% | |
| Industrials | 4.9% | |
| Other | 0.1% |
What changed from Q3 2024
- Buy CVS Health CVS 7.8% of the 13F
- Buy Molson Coors Beverage TAP 4.4% of the 13F
- Buy Cleveland-Cliffs CLF 3.6% of the 13F
- Buy Revance Therapeutics RVNC 0.0% of the 13F
- Add 342% Kraft Heinz KHC 2.4% → 6.5%
- Add 4285% ATS ATS 0.1% → 4.7%
- Add 39% Helmerich & Payne HP 1.5% → 1.6%
- Add 24% Bank of Nova Scotia BNS 1.4% → 1.2%
- Add 41% Pfizer PFE 1.2% → 1.1%
- Add 7% Garrett Motion GTX 0.2% → 0.2%
- Reduce 61% Capri Holdings CPRI 0.8% → 0.1%
- Reduce 18% Xeris Biopharma XERS 0.0% → 0.0%
- Sell Alphabet GOOGL was 4.1%
- Sell Intel INTC was 0.4%
- Sell Restaurant Brands International QSR was 0.3%
- Sell Tegna TGNA was 0.0%